Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun:146:248-266.
doi: 10.1016/j.addr.2018.06.021. Epub 2018 Jul 5.

Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives

Niranjan G Kotla  1 , Shubhasmin Rana  2 , Gandhi Sivaraman  3 , Omprakash Sunnapu  3 , Praveen K Vemula  3 , Abhay Pandit  2 , Yury Rochev  4
Affiliations
Review

Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives

Niranjan G Kotla et al. Adv Drug Deliv Rev. 2019 Jun.

Abstract

Oral colon-specific delivery systems emerged as the main therapeutic cargos by making a significant impact in the field of modern medicine for local drug delivery in intestinal inflammation. The site-specific delivery of therapeutics (aminosalicylates, glucocorticoids, biologics) to the ulcerative mucus tissue can provide prominent advantages in mucosal healing (MH). Attaining gut mucosal healing and anti-fibrosis are main treatment outcomes in inflammatory bowel disease (IBD). The pharmaceutical strategies that are commonly used to achieve a colon-specific drug delivery system include time, pH-dependent polymer coating, prodrug, colonic microbiota-activated delivery systems and a combination of these approaches. Amongst the different approaches reported, the use of biodegradable polysaccharide coated systems holds great promise in delivering drugs to the ulcerative regions. The present review focuses on major physiological gastro-intestinal tract challenges involved in altering the pharmacokinetics of delivery systems, pathophysiology of MH and fibrosis, reported drug-polysaccharide cargos and focusing on conventional to advanced disease responsive delivery strategies, highlighting their limitations and future perspectives in intestinal inflammation therapy.

Keywords: Colon-specific drug delivery; Crohn's disease; Inflammatory bowel disease; Microbiota-activated drug delivery; Mucosal healing; Polysaccharides; Prodrug; Ulcerative colitis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

Substances

LinkOut - more resources